NeuroOne Medical Technolo...

NASDAQ: NMTC · Real-Time Price · USD
0.83
-0.03 (-3.47%)
At close: Aug 14, 2025, 3:59 PM
0.87
4.82%
Pre-market: Aug 15, 2025, 06:06 AM EDT

NeuroOne Medical Income Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
Revenue
3.45M 1.95M 171.17K 178.15K
Cost of Revenue
2.37M 1.5M 241.96K 275.89K
Gross Profit
1.08M 456.52K -70.79K -97.75K
Operating Income
-11.89M -11.96M -10.03M -10.22M
Interest Income
n/a n/a n/a n/a
Pretax Income
-12.32M -11.86M -10M -9.95M
Net Income
-12.32M -11.86M -10M -9.95M
Selling & General & Admin
7.9M 6.93M 6.98M 6.26M
Research & Development
5.07M 6.94M 4.93M 3.93M
Other Expenses
n/a -1.46M 31.15K n/a
Operating Expenses
12.97M 12.41M 9.96M 10.12M
Interest Expense
228.99K n/a n/a 3.05K
Selling & Marketing Expenses
n/a 173.43K 270.61K 338.84K
Cost & Expenses
15.34M 13.91M 10.2M 10.4M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
26.76M 18.12M 16M 10.7M
Shares Outstanding (Diluted)
26.76M 18.12M 16M 10.7M
EPS (Basic)
-0.46 -0.65 -0.63 -0.93
EPS (Diluted)
-0.46 -0.65 -0.63 -0.93
EBITDA
-11.84M -11.76M -9.91M -9.8M
EBIT
-12.09M -11.96M -10.03M -9.95M
Depreciation & Amortization
246.79K 199.27K 226.21K 147.13K